EGF receptor ligands

Experimental Cell Research

Volumn 284, Issue 1, 2003, Pages 2-13

  Harris, Raymond C ^a   Chung, Eunkyung ^a   Coffey, Robert J ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; BETACELLULIN; BINDING PROTEIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIGEN; EPIREGULIN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; RAS PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG;

CELL POLARITY; CELL SURFACE; CELL TRANSPORT; EPITHELIUM CELL; GENE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TRANSPORT; RECEPTOR UPREGULATION; REVIEW; TRANSACTIVATION;

EID: 0037429706     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(02)00105-2     Document Type: Review

References (116)

1. Massague J. Transforming growth factors-α J. Biol. Chem. 265:1990;21393-21396.
2. Shoyab M., McDonald V.L., Bradley J.G., Todaro G.J. Amphiregulin a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate- treated human breast adenocarcinoma cell line MCF-7 . Proc. Natl. Acad. Sci. USA. 85:1988;6528-6532.
3. Toyoda H., Komurasaki T., Uchida D., Takayama Y., Isobe T., Okuyama T., Hanada K. Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J. Biol. Chem. 270:1995;7495-7500.
4. Strachan L., Murison J.G., Prestidge R.L., Sleeman M.A., Watson J.D., Kumble K.D. Cloning and biological activity of epigen, a novel member of the epidermal growth factor superfamily. J. Biol. Chem. 276:2001;18265-18271.
5. Brown C.L., Coffey R.J., Dempsey P.J. The proamphiregulin cytoplasmic domain is required for basolateral sorting, but is not essential for constitutive or stimulus-induced processing in polarized Madin-Darby canine kidney cells. J. Biol. Chem. 276:2001;29538-29549.
6. Kuwada S.K., Li X.F., Damstrup L., Dempsey P.J., Coffey R.J., Wiley H.S. The dynamic expression of the epidermal growth factor receptor and epidermal growth factor ligand family in a differentiating intestinal epithelial cell line. Growth Factors. 17:1999;139-153.
7. Damstrup L., Kuwada S.K., Dempsey P.J., Brown C.L., Hawkey C.J., Poulsen H.S., Wiley H.S., Coffey R.J. Jr. Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis. Br. J. Cancer. 80:1999;1012-1019.
8. Dempsey P.J., Meise K.S., Yoshitake Y., Nishikawa K., Coffey R.J. Apical enrichment of human EGF precursor in Madin-Darby canine kidney cells involves preferential basolateral ectodomain cleavage sensitive to a metalloprotease inhibitor. J. Cell Biol. 138:1997;747-758.
9. Dempsey P.J., Coffey R.J. Basolateral targeting and efficient consumption of transforming growth factor-alpha when expressed in Madin-Darby canine kidney cells. J. Biol. Chem. 269:1994;16878-16889.
10. Nakamura K., Iwamoto R., Mekada E. Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites. J. Cell Biol. 129:1995;1691-1705.
11. Burdick J.S., Chung E., Tanner G., Sun M., Paciga J.E., Cheng J.Q., Washington K., Goldenring J.R., Coffey R.J. Treatment of Menetrier's disease with a monoclonal antibody against the epidermal growth factor receptor. N. Engl. J. Med. 343:2000;1697-1701.
12. Sternberg P.W., Horvitz H.R. Pattern formation during vulval development in C. elegans. Cell. 44:1986;761-772.
13. Kornfeld K. Vulval development in Caenorhabditis elegans. Trends Genet. 13:1997;55-61.
14. Hajnal A., Whitfield C.W., Kim S.K. Inhibition of Caenorhabditis elegans vulval induction by gap-1 and by let-23 receptor tyrosine kinase. Genes Dev. 11:1997;2715-2728.
15. Luetteke N.C., Qiu T.H., Peiffer R.L., Oliver P., Smithies O., Lee D.C. TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell. 73:1993;263-278.
16. Mann G.B., Fowler K.J., Gabriel A., Nice E.C., Williams R.L., Dunn A.R. Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell. 73:1993;249-261.
17. Miettinen P.J., Berger J.E., Meneses J., Phung Y., Pedersen R.A., Werb Z., Derynck R. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature. 376:1995;337-341.
18. Sibilia M.F., Wagner E. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science. 269:1995;234-238.
19. Threadgill D.W., Dlugosz A.A., Hansen L.A., Tennenbaum T., Lichti U., Yee D., LaMantia C., Mourton T., Herrup K.C., Harris R., Barnard J.A., Yuspa S.H., Coffey R.J., Magnuson T. Targeted disruption of mouse EGF receptor effect of genetic background on mutant phenotype . Science. 269:1995;230-234.
20. Berkowitz E.A., Seroogy K.B., Schroeder J.A., Russell W.E., Evans E.P., Riedel R.F., Phillips H.K., Harrison C.A., Lee D.C., Luetteke N.C. Characterization of the mouse transforming growth factor alpha gene its expression during eyelid development and in waved 1 tissues . Cell Growth Differ. 7:1996;1271-1282.
21. Fernandez-Larrea J., Merlos-Suarez A.M., Urena J., Baselga J., Arribas J. A role for a PDZ protein in the early secretory pathway for the targeting of proTGF-alpha to the cell surface. Mol. Cell. 3:1999;423-433.
22. Barr F.A., Preisinger C., Kopajtich R., Korner R. Golgi matrix proteins interact with p24 cargo receptors and aid their efficient retention in the Golgi apparatus. J. Cell Biol. 155:2001;885-891.
23. Higashiyama S., Abraham J.A., Miller J., Fiddes J.C., Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science. 251:1991;936-993.
24. Higashiyama S., Lau K.E., Besner G.A., Abraham J., Klagsbrun M. Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J. Biol. Chem. 267:1992;6205-6212.
25. Peoples G.E., Blotnick S., Takahashi K., Freeman M.R., Klagsbrun M., Eberlein T.J. T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor a potential pathologic role . Proc. Natl. Acad. Sci. USA. 92:1995;6547-6551.
26. Powell P.P., Klagsbrun M., Abraham J.A., Jones R.C. Eosinophils expressing heparin-binding EGF-like growth factor mRNA localize around lung microvessels in pulmonary hypertension. Am. J. Pathol. 143:1993;784-793.
27. Barnard J.A., Graves-Deal R., Pittelkow M.R., DuBois R., Cook P., Ramsey G.W., Bishop P.R., Damstrup L., Coffey R.J. Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family. J. Biol. Chem. 269:1994;22817-22822.
28. Raab G., Klagsbrun M. Heparin-binding EGF-like growth factor. Biochim. Biophys. Acta. 1333:1997;F179-F199.
29. Homma T., Sakai M., Cheng H.F., Yasuda T., Coffey R.J. Jr., Harris R.C. Induction of heparin-binding epidermal growth factor-like growth factor mRNA in rat kidney after acute injury. J. Clin. Invest. 96:1995;1018-1025.
30. Marikovsky M., Breuing K., Liu P.Y., Eriksson E., Higashiyama S., Farber P., Abraham J., Klagsbrun M. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc. Nat. Acad. Sci. USA. 90:1993;3889-3893.
31. Raab G., Kover K., Paria B.C., Dey S.K., Ezzell R.M., Klagsbrun M. Mouse preimplantation blastocysts adhere to cells expressing the transmembrane form of heparin-binding EGF-like growth factor. Development. 122:1996;637-645.
32. Miyagawa J., Higashiyama S., Kawata S., Inui Y., Tamura S., Yamamoto K., Nishida M., Nakamura T., Yamashita S., Matsuzawa Y., et al. Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques. J. Clin. Invest. 95:1995;404-411.
33. Raab G., Higashiyama S., Hetelekidis S., Abraham J.A., Damm D., Ono M., Klagsbrun M. Biosynthesis and processing by phorbol ester of the cells surface-associated precursor form of heparin-binding EGF-like growth factor. Biochem. Biophys. Res. Commun. 204:1994;592-597.
34. Naglich J.G., Metherall J.E., Russell D.W., Eidels L. Expression cloning of a diphtheria toxin receptor identity with a heparin-binding EGF-like growth factor precursor . Cell. 69:1992;1051-1061.
35. Iwamoto R., Higashiyama S., Mitamura T., Taniguchi N., Klagsbrun M., Mekada E. Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. EMBO J. 13:1994;2322-2330.
36. Mitamura T., Higashiyama S., Taniguchi N., Klagsbrun M., Mekada E. Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity. J. Biol. Chem. 270:1995;1015-1019.
37. Suzuki M., Raab G., Moses M.A., Fernandez C.A., Klagsbrun M. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. J. Biol. Chem. 272:1997;31730-31737.
38. Yu W.H., Woessner J.F. Jr., McNeish J.D., Stamenkovic I. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev. 16:2002;307-323.
39. Izumi Y., Hirata M., Hasuwa H., Iwamoto R., Umata T., Miyado K., Tamai Y., Kurisaki T., Sehara-Fujisawa A., Ohno S., Mekada E. A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 17:1998;7260-7272.
40. Weskamp G., Cai H., Brodie T.A., Higashyama S., Manova K., Ludwig T., Blobel C.P. Mice lacking the metalloprotease-disintegrin MDC9 (ADAM9) have no evident major abnormalities during development or adult life. Mol. Cell. Biol. 22:2002;1537-1544.
41. Sunnarborg S.W., Hinkle C.L., Stevenson M., Russell W.E., Raska C.S., Peschon J.J., Castner B.J., Gerhart M.J., Paxton R.J., Black R.A., Lee D.C. Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J. Biol. Chem. 277:2002;12838-12845.
42. Asakura M., Kitakaze M., Takashima S., Liao Y., Ishikura F., Yoshinaka T., Ohmoto H., Node K., Yoshino K., Ishiguro H., Asanuma H., Sanadam S., Matsumura Y., Takeda H., Beppu S., Tada M., Hori M., Higashiyama S. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF metalloproteinase inhibitors as a new therapy . Nat. Med. 8:2002;35-40.
43. Yan Y., Shirakabe K., Werb Z. The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J. Cell Biol. 158:2002;221-226.
44. Suzuki A., Kadota N., Hara T., Nakagami Y., Izumi T., Takenawa T., Sabe H., Endo T. Meltrin alpha cytoplasmic domain interacts with SH3 domains of Src and Grb2 and is phosphorylated by v-Src. Oncogene. 19:2000;5842-5850.
45. Ono M., Raab G., Lau K., Abraham J.A., Klagsbrun M. Purification and characterization of transmembrane forms of heparin-binding EGF-like growth factor. J. Biol. Chem. 269:1994;31315-31321.
46. Higashiyama S., Iwamoto R., Goishi K., Raab G., Taniguchi N., Klagsbrun M., Mekada E. The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J. Cell Biol. 128:1995;929-938.
47. Takemura T., Kondo S., Homma T., Sakai M., Harris R.C. The membrane-bound form of heparin-binding epidermal growth factor-like growth factor promotes survival of cultured renal epithelial cells. J. Biol. Chem. 272:1997;31036-31042.
48. Takemura T., Hino S., Murata Y., Yanagida H., Okada M., Yoshioka K., Harris R.C. Coexpression of CD9 augments the ability of membrane-bound heparin-binding epidermal growth factor-like growth factor (proHB-EGF) to preserve renal epithelial cell viability. Kidney Int. 55:1999;71-81.
49. Sakuma T., Higashiyama S., Hosoe S., Hayashi S., Taniguchi N. CD9 antigen interacts with heparin-binding EGF-like growth factor through its heparin-binding domain. J. Biochem. (Tokyo). 122:1997;474-480.
50. Maecker H.T., Todd S.C., Levy S. The tetraspanin superfamily molecular facilitators . FASEB J. 11:1997;428-442.
51. Ikeyama S., Koyama M., Yamaoko M., Sasada R., Miyake M. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J. Exp. Med. 177:1993;1231-1237.
52. Cajot J.F., Sordat I., Silvestre T., Sordat B. Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. Cancer Res. 57:1997;2593-2597.
53. Miyake M., Nakano K., Itoi S.I., Koh T., Taki T. Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer. Cancer Res. 56:1996;1244-1249.
54. Lagaudriere-Gesbert C., Le Naour F., Lebel-Binay S., Billard M., Lemichez E., Boquet P., Boucheix C., Conjeaud H., Rubinstein E. Functional analysis of four tetraspans, CD9, CD53, CD81, and CD82, suggests a common role in costimulation, cell adhesion, and migration only CD9 upregulates HB-EGF activity . Cell Immunol. 182:1997;105-112.
55. Nakamura K., Mitamura T., Takahashi T., Kobayashi T., Mekada E. Importance of the major extracellular domain of CD9 and the epidermal growth factor (EGF)-like domain of heparin-binding EGF-like growth factor for up-regulation of binding and activity. J. Biol. Chem. 275:2000;18284-18290.
56. Symington B.E., Takada Y., Carter W.G. Interaction of integrins alpha 3 beta 1 and alpha 2 beta 1 potential role in keratinocyte intercellular adhesion . J. Cell Biol. 120:1993;523-535.
57. Symington B.E., Carter W.G. Modulation of epidermal differentiation by epiligrin and integrin alpha 3 beta 1. J. Cell Sci. 108:1995;831-838.
58. Goishi K., Higashiyama S., Klagsbrun M., Nakano N., Umata T., Ishikawa M., Mekada E., Taniguchi N. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor conversion from juxtacrine to paracrine growth factor activity . Mol. Biol. Cell. 6:1995;967-980.
59. Fukuyama R., Shimizu N. Detection of epidermal growth factor receptors and E-cadherins in the basolateral membrane of A431 cells by laser scanning fluorescence microscopy. Jpn. Cancer Res. 82:1991;8-11.
60. Woods D.F., Bryant P.J. Apical junctions and cell signalling in epithelia. J. Cell Sci. Suppl. 17:1993;171-181.
61. Hoschuetzky H., Aberle H., Kemler R. Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J. Cell Biol. 127:1994;1375-1380.
62. Larjava H., Peltonen J., Akiyama S.K., Yamada S.S., Gralnick H.R., Uitto J., Yamada K.M. Novel function for beta 1 integrins in keratinocyte cell-cell interactions. J. Cell Biol. 110:1990;803-815.
63. Simon E.E., Liu C.H., Das M., Nigam S., Broekelmann T.J., McDonald J.A. Characterization of integrins in cultured human renal cortical tubule epithelial cells. Am. J. Physiol. 267:1994;F612-F623.
64. Carter W.G., Wayner E.A., Bouchard T.S., Kaur P. The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells. J. Cell Biol. 110:1990;1387-1404.
65. Higashiyama S., Abraham J.A., Klagsbrun M. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration dependence on interactions with cell surface heparan sulfate . J. Cell Biol. 122:1993;933-940.
66. Piepkorn M., Pittelkow M.R., Cook P.W. Autocrine regulation of keratinocytes the emerging role of heparin-binding, epidermal growth factor-related growth factors . J. Invest. Dermatol. 111:1998;715-721.
67. St. John T., Meyer J., Idzerda R., Gallatin W.M. Expression of CD44 confers a new adhesive phenotype on transfected cells. Cell. 60:1990;45-52.
68. Bennett K.L., Jackson D.G., Simon J.C., Tanczos E., Peach R., Modrell B., Stamenkovic I., Plowman G., Aruffo A. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J. Cell Biol. 128:1995;687-698.
69. van der Voort R., Taher T.E., Wielenga V.J., Spaargaren M., Prevo R., Smit L., David G., Hartmann G., Gherardi E., Pals S.T. Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. J. Biol. Chem. 274:1999;6499-6506.
70. Okamoto I., Kawano Y., Tsuiki H., Sasaki J., Nakao M., Matsumoto M., Suga M., Ando M., Nakajima M., Saya H. CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration. Oncogene. 18:1999;1435-1446.
71. Okamoto I., Kawano Y., Matsumoto M., Suga M., Kaibuchi K., Ando M., Saya H. Regulated CD44 cleavage under the control of protein kinase C, calcium influx, and the Rho family of small G proteins. J. Biol. Chem. 274:1999;25525-25534.
72. Ridley A.J. Rho family proteins and regulation of the actin cytoskeleton. Prog Mol. Subcell. Biol. 22:1999;1-22.
73. Chen J., Cohn J.A., Mandel L.J. Dephosphorylation of ezrin as an early event in renal microvillar breakdown and anoxic injury. Proc. Natl. Acad. Sci. USA. 92:1995;7495-7499.
74. Gautreau A., Poullet P., Louvard D., Arpin M. Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. USA. 96:1999;7300-7305.
75. Brooke J.S., Cha J.H., Eidels L. Latent transforming growth factor beta-binding protein-3 and fibulin-1C interact with the extracellular domain of the heparin-binding EGF-like growth factor precursor. BMC Cell Biol. 3:2002;2.
76. Lin J., Hutchinson L., Gaston S.M., Raab G., Freeman M.R. BAG-1 is a novel cytoplasmic binding partner of the membrane form of heparin-binding EGF-like growth factor a unique role for proHB-EGF in cell survival regulation . J. Biol. Chem. 276:2001;30127-30132.
77. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 402:1999;884-888.
78. Eguchi S., Dempsey P.J., Frank G.D., Motley E.D., Inagami T. Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J. Biol. Chem. 276:2001;7957-7962.
79. Pierce K.L., Tohgo A., Ahn S., Field M.E., Luttrell L.M., Lefkowitz R.J. Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors a co-culture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding . J. Biol. Chem. 276:2001;23155-23160.
80. Chen J.K., Capdevila J., Harris R.C. Heparin-binding EGF-like growth factor mediates the biological effects of P450 arachidonate epoxygenase metabolites in epithelial cells. Proc. Natl. Acad. Sci. USA. 99:2002;6029-6034.
81. Kalmes A., Daum G., Clowes A.W. EGFR transactivation in the regulation of SMC function. Ann. NY Acad. Sci. 947:2001;42-54.
82. McCole D.F., Keely S.J., Coffey R.J., Barrett K.E. Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbachol requires extracellular release of transforming growth factor-alpha. J. Biol. Chem. 277:2002;42603-42612.
83. G. Carpenter, Epidermal growth factor, Annu. Rev. Biochem. 48 (1979) 193-230.
84. Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Annu. Rev. Biochem. 56:1987;881-934.
85. Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J. Biol. Chem. 237:1962;1555-1562.
86. Dong J., Wiley H.S. Trafficking and proteolytic release of epidermal growth factor receptor ligands are modulated by their membrane-anchoring domains. J. Biol. Chem. 275:2000;557-564.
87. Brown C.L., Meise K.S., Plowman G.D., Coffey R.J., Dempsey P.J. Cell surface ectodomain cleavage of human amphiregulin precursor is sensitive to a metalloprotease inhibitor. Release of a predominant N-glycosylated 43-kDa soluble form. J. Biol. Chem. 273:1998;17258-17268.
88. Nylander N., Smith L.T., Underwood R.A., Piepkorn M. Topography of amphiregulin expression in cultured human keratinocytes colocalization with the epidermal growth factor receptor and CD44 . In Vitro Cell. Dev. Biol. Anim. 34:1998;182-188.
89. Inui S., Higashiyama S., Hashimoto K., Higashiyama M., Yoshikawa K., Taniguchi N. Possible role of coexpression of CD9 with membrane-anchored heparin-binding EGF-like growth factor and amphiregulin in cultured human keratinocyte growth. J. Cell. Physiol. 171:1997;291-298.
90. Luetteke N.C., Qiu T.H., Fenton S.E., Troyer K.L., Riedel R.F., Chang A., Lee D.C. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development. 126:1999;2739-2750.
91. Troyer K.L., Luetteke N.C., Saxon M.L., Qiu T.H., Xian C.J., Lee D.C. Growth retardation, duodenal lesions, and aberrant ileum architecture in triple null mice lacking EGF, amphiregulin, and TGF-alpha. Gastroenterology. 121:2001;68-78.
92. Cook P.W., Piepkorn M., Clegg C.H., Plowman G.D., DeMay J.M., Brown J.R., Pittelkow M.R. Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. J. Clin. Invest. 100:1997;2286-2294.
93. Cook P.W., Ashton N.M., Karkaria C.E., Siess D.C., Shipley G.D. Differential effects of a heparin antagonist (hexadimethrine) or chlorate on amphiregulin, basic fibroblast growth factor, and heparin-binding EGF-like growth factor activity. J. Cell. Physiol. 163:1995;418-429.
94. Sasada R., Ono Y., Taniyama Y., Shing Y., Folkman J., Igarashi K. Cloning and expression of cDNA encoding human betacellulin, a new member of the EGF family. Biochem. Biophys. Res. Commun. 190:1993;1173-1179.
95. Dunbar A.J., Goddard C. Structure-function and biological role of betacellulin. Int. J. Biochem. Cell. Biol. 32:2000;805-815.
96. Dunbar A.J., Priebe I.K., Belford D.A., Goddard C. Identification of betacellulin as a major peptide growth factor in milk purification, characterization and molecular cloning of bovine betacellulin . Biochem. J. 344:1999;713-721. Pt 3.
97. Seno M., Tada H., Kosaka M., Sasada R., Igarashi K., Shing Y., Folkman J., Ueda M., Yamada H. Human betacellulin, a member of the EGF family dominantly expressed in pancreas and small intestine, is fully active in a monomeric form. Growth Factors. 13:1996;181-191.
98. Tada H., Sasada R., Kawaguchi Y., Kojima I., Gullick W.J., Salomon D.S., Igarashi K., Seno M., Yamada H. Processing and juxtacrine activity of membrane-anchored betacellulin. J. Cell. Biochem. 72:1999;423-434.
99. Toyoda H., Komurasaki T., Uchida D., Morimoto S. Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family. Biochem. J. 326:1997;69-75.
100. Zhu Z., Kleeff J., Friess H., Wang L., Zimmermann A., Yarden Y., Buchler M.W., Korc M. Epiregulin is Up-regulated in pancreatic cancer and stimulates pancreatic cancer cell growth. Biochem. Biophys. Res. Commun. 273:2000;1019-1024.
101. Komurasaki T., Toyoda H., Uchida D., Nemoto N. Mechanism of growth promoting activity of epiregulin in primary cultures of rat hepatocytes. Growth Factors. 20:2002;61-69.
102. Shirakata Y., Komurasaki T., Toyoda H., Hanakawa Y., Yamasaki K., Tokumaru S., Sayama K., Hashimoto K. Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes. J. Biol. Chem. 275:2000;5748-5753.
103. Shelly M., Pinkas-Kramarski R., Guarino B.C., Waterman H., Wang L.M., Lyass L., Alimandi M., Kuo A., Bacus S.S., Pierce J.H., Andrews G.C., Yarden Y. Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes. J. Biol. Chem. 273:1998;10496-10505.
104. Lee S.B., Huang K., Palmer R., Truong V.B., Herzlinger D., Kolquist K.A., Wong J., Paulding C., Yoon S.K., Gerald W., Oliner J.D., Haber D.A. The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin. Cell. 98:1999;663-673.
105. Campbell S.L., Khosravi-Far R., Rossman K.L., Clark G.J., Der C.J. Increasing complexity of Ras signaling. Oncogene. 17:1998;1395-1413.
106. Sibilia M., Fleischmann A., Behrens A., Stingl L., Carroll J., Watt F.M., Schlessinger J., Wagner E.F. The EGF receptor provides an essential survival signal for SOS- dependent skin tumor development. Cell. 102:2000;211-220.
107. Gangarosa L.M., Sizemore N., Graves-Deal R., Oldham S.M., Der C.J., Coffey R.J. A raf-independent epidermal growth factor receptor autocrine loop is necessary for Ras transformation of rat intestinal epithelial cells. J. Biol. Chem. 272:1997;18926-18931.
108. Sizemore N., Cox A.D., Barnard J.A., Oldham S.M., Reynolds E.R., Der C.J., Coffey R.J. Pharmacological inhibition of Ras-transformed epithelial cell growth is linked to down-regulation of epidermal growth factor-related peptides. Gastroenterology. 117:1999;567-576.
109. Chin L., Pomerantz J., Polsky D., Jacobson M., Cohen C., Cordon-Cardo C., Horner J.W. 2nd, DePinho R.A. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev. 11:1997;2822-2834.
110. Beerli R.R., Hynes N.E. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J. Biol. Chem. 271:1996;6071-6076.
111. Elenius K., Paul S., Allison G., Sun J., Klagsbrun M. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J. 16:1997;1268-1278.
112. Paria B.C., Elenius K., Klagsbrun M., Dey S.K. Heparin-binding EGF-like growth factor interacts with mouse blastocysts independently of ErbB1 a possible role for heparan sulfate proteoglycans and ErbB4 in blastocyst implantation . Development. 126:1999;1997-2005.
113. Elenius K., Choi C.J., Paul S., Santiestevan E., Nishi E., Klagsbrun M. Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase. Oncogene. 18:1999;2607-2615.
114. Sawyer C., Hiles I., Page M., Crompton M., Dean C. Two erbB-4 transcripts are expressed in normal breast and in most breast cancers. Oncogene. 17:1998;919-924.
115. Kainulainen V., Sundvall M., Maatta J.A., Santiestevan E., Klagsbrun M., Elenius K. A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis. J. Biol. Chem. 275:2000;8641-8649.
116. Massague J., Pandiella A. Membrane-anchored growth factors. Annu. Rev. Biochem. 62:1993;515-541.